APPLICATIONS PUBLISHED 14 MAY 2003
Published: 1-Nov-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Inhaleable spray dried 4-helix bundle protein powders having minimised aggregation
Inhale Therapeutic Systems 1309312*
Compsn material and process for increasing bioavailability and activity of a beneficent agent
Ceramatec 1309313*
Method of making tablets and tablet compsn produced therefrom
Rexall Sundown 1309314*
Rapidly disintegrating oral formulation of a cytotoxygenase-2 inhibitor
Pharmacia 1309315*
Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
Pharmacia 1309316*
Pharmaceutical compsn comprising amlodipine maleate
Synthon Licensing 1309317*
Consumable container
Machines Industrielles Etablissements 1309318*
Pharmaceutical, effervescent formulation containing ramipril
Hexal 1309319*
Antheliminthic agents for the prevention of parasitic infections in humans and animals II
Bayer 1309320*
Compsns and methods for inhibiting islet dysfunction and autoimmune disorders
The Lawson Research Institute; Universite Catholique de Louvain 1309321*
Method of treating neurodegenerative disorders of the retina and optic nerve head
Alcon 1309322*
Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid
Alcon 1309323*
Anticonvulsant derivatives useful for treating and prevention the development of type II diabetes mellitus and syndrome X
Ortho-McNeil Pharmaceutical 1309324*
Anticonvulsant derivatives useful for the treatment of depression
Ortho-McNeil Pharmaceutical 1300325*
A therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives
Korea Institute of Oriental Medicine 1309326*
Pharmaceutical compsns of oestrogenic agents
Wyeth 1309327*
COX-2 inhibitors and the prevention of the side effects of radiation therapy
Herbst, Arthur L; Weichselbaum, Ralph R 1309328*
Therapeutic combination of a CETP inhibitor and atorvastatin
Pfizer Products 1309329*
Photosensitisers with ligand targeting properties for tumour therapy
CeramOptec 1309330*
Medicine for fighting against sexual dysfunction
Adenomed 1309331*
Macrolide formulations for inhalation and methods of treatment of endobronchial infections
Chiron 1309332*
Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections
Control-Ox 1309333*
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
Oncolytics Biotech 1309334*
Use of extracts from Ginkgo biloba leaves for inducing dreams
Medichemie 1309335*
Derivatives of Laspartomycin and preparation and use thereof
Micrologix Biotech 1309336*
Use of GADD34 or PCBA polypeptides in the treatment of cerebral ischaemic damage
The University Court of the University of Glasgow 1309337*
Pharmaceutical compsn comprising TRKAIG2 for use in the prevention and/or treatment of cancer
The University of Bristol 1309338*
Stimulating neutrophil function to treat inflammatory bowel disease
Washington University 1309339*
High mannose proteins and methods of making high mannose proteins
Transkaryotic Therapies 1309340*
Prevention and treatment of Alzheimer's disease
Lannfelt, Lars 1309341*
Production of human chimeric human papillomavirus
Merck 1309342*
Vaccines against cytokines and growth factors derived from malignant tumours
Neovacs 1309343*
Oral solid dose vaccine
SmithKline Beecham Biologicals 1309344*
Cathelicidins as vaccine adjuvants
Cistem Biotechnologies 1309345*
Treatment of HIV-1 infection and inflammatory disease using cyclophilin receptor antagonists
The Picower Institute for Medical Research 1309346*
Method and compsn for altering a B cell mediated pathology
Favrille 1309347*
Prophylactic and therapeutic monoclonal antibodies against Vaccinia virus antigens
US Army Medical Research Institute of Infectious Diseases 1309348*
Pharmaceutical compsns and method for the treatment of retroviral infections
Stichting REGA 1309349*
Chelerythyrine-based therapies for cancer
Arch Development Corp 1309350*
Dermatological formulation
Glaxo Group 1309351*
Antifungal ketoconazole compsns for topical use
Diomed Developments 1309352*
Flavone-containing plant extract solutions having improved storage and heat stability
Dr Wilmar Schwabe 1309353*
Therapeutic polyesters and polyamides
Rutgers, The State University 1309354*
Peptide and peptide mimetic conjugates with integrin-inhibitor properties
Merck 1309355*
Tissue marking using biocompatible microparticles
Carbon Medical Technologies 1309356*
